Prelu-2 TR Interactions
There are 172 drugs known to interact with Prelu-2 TR (phendimetrazine), along with 15 disease interactions, and 3 alcohol/food interactions. Of the total drug interactions, 43 are major, 127 are moderate, and 2 are minor.
- View all 172 medications that may interact with Prelu-2 TR
- View Prelu-2 TR alcohol/food interactions (3)
- View Prelu-2 TR disease interactions (15)
Most frequently checked interactions
View interaction reports for Prelu-2 TR (phendimetrazine) and the medicines listed below.
- Amicar (aminocaproic acid)
- Cipro XR (ciprofloxacin)
- clarithromycin
- clonidine
- cyclosporine
- Cytotec (misoprostol)
- denileukin diftitox
- dexfenfluramine
- diflunisal
- Digox (digoxin)
- dipyridamole
- Fastin (phentermine)
- gatifloxacin
- heparin
- hydroxychloroquine
- Jantoven (warfarin)
- Lexiscan (regadenoson)
- lopinavir / ritonavir
- mannitol
- Meridia (sibutramine)
- Metopirone (metyrapone)
- MS Contin (morphine)
- Ogivri (trastuzumab)
- pimozide
- Pondimin (fenfluramine)
- Proleukin (aldesleukin)
- propafenone
- propranolol
- Propulsid (cisapride)
- Quinidex Extentabs (quinidine)
Prelu-2 TR alcohol/food interactions
There are 3 alcohol/food interactions with Prelu-2 TR (phendimetrazine).
Prelu-2 TR disease interactions
There are 15 disease interactions with Prelu-2 TR (phendimetrazine) which include:
- cardiovascular
- glaucoma
- agitation
- cardiac disease
- glaucoma
- hypertension
- psychiatric disorders
- pulmonary hypertension
- substance abuse
- tics
- diabetes
- liver disease
- renal dysfunction
- seizure disorders
- diabetics
More about Prelu-2 TR (phendimetrazine)
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.